Adult congenital heart disease: Special considerations for COVID-19 and vaccine allocation/prioritization

[1]  E. Oechslin,et al.  Anatomical complexity does not predict outcomes after COVID-19 in adults with congenital heart disease , 2021, Heart.

[2]  M. Schwerzmann,et al.  COVID-19 in Adults With Congenital Heart Disease , 2021, Journal of the American College of Cardiology.

[3]  M. Schwerzmann,et al.  Clinical outcome of COVID-19 in patients with adult congenital heart disease , 2021, Heart.

[4]  M. Vaduganathan,et al.  ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization , 2021, Journal of the American College of Cardiology.

[5]  G. Liguori,et al.  COVID-19 as a confounding factor in a child submitted to staged surgical palliation of hypoplastic left heart syndrome: One of the first reports of SARS-CoV-2 infection in patients with congenital heart disease , 2020, The Journal of Thoracic and Cardiovascular Surgery.

[6]  G. Luciani,et al.  COVID-19 Vaccine Priority Access for Adults and Children with Congenital Heart Disease: A Statement of the Italian Society of Pediatric Cardiology , 2021, Congenital Heart Disease.

[7]  J. Simpson,et al.  Impact of COVID-19 on patients with congenital heart disease , 2020, Cardiology in the Young.

[8]  M. Schwerzmann,et al.  Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease , 2020, European heart journal.

[9]  J. Ryan,et al.  A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care , 2020, Annals of the American Thoracic Society.

[10]  G. Di Salvo,et al.  Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis , 2020, PloS one.

[11]  J. Ryan,et al.  A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with PAH or CTEPH and Impact on the Process of Care. , 2020, Annals of the American Thoracic Society.

[12]  H. Cokugras,et al.  SARS-CoV-2 infection in children , 2020, Turk pediatri arsivi.

[13]  P. Ferrero,et al.  COVID-19 in adult patients with CHD: a matter of anatomy or comorbidities? , 2020, Cardiology in the Young.

[14]  G. Di Salvo,et al.  COVID-19 and Congenital Heart Disease: Results from a Nationwide Survey , 2020, Journal of clinical medicine.

[15]  Irim Salik,et al.  Tetralogy of Fallot palliation in a COVID-19 positive neonate , 2020, Journal of Clinical Anesthesia.

[16]  V. Chinchilli,et al.  The association of cardiovascular disease and other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis , 2020, medRxiv.

[17]  Kanwal M. Farooqi,et al.  The Impact of Coronavirus disease 2019 (COVID-19) on Patients with Congenital Heart Disease across the Lifespan: The Experience of an Academic Congenital Heart Disease Center in New York City. , 2020, Journal of the American Heart Association.

[18]  M. Priestley,et al.  Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. , 2020, JAMA pediatrics.

[19]  Amit N. Patel,et al.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 , 2020, The New England journal of medicine.

[20]  Bryan H. Goldstein,et al.  Resource Allocation and Decision Making for Pediatric and Congenital Cardiac Catheterization During the Novel Coronavirus SARS-CoV-2 (COVID-19) Pandemic: A U.S. Multi-Institutional Perspective. , 2020, The Journal of invasive cardiology.

[21]  M. Gatzoulis,et al.  The globe on the spotlight: Coronavirus disease 2019 (Covid-19) , 2020, International Journal of Cardiology.

[22]  Weiyi Tan,et al.  Title : The Cardiovascular Burden of Coronavirus Disease 2019 ( COVID-19 ) with a Focus on Congenital Heart Disease Author Names and Affiliations : , 2022 .

[23]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[24]  V. Cheng,et al.  Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection , 2007, Clinical Microbiology Reviews.